Slides
Page 1
Third Quarter 2026 Results November 4, 2026 Alexandre BLUM CFO Philippe KEHREN CEO
Page 2
This presentation may contain forward-looking information. Forward-looking statements describe expectations, plans, strategies, goals, future events or intentions. Discussions with One IM described in this presentation remain ongoing and there can be no assurance that these discussions will result in a definitive agreement or that any transaction will be consummated. The achievement of forward-looking statements contained in this presentation is subject to risks and uncertainties relating to a number of factors, including general economic factors, interest rate and foreign currency exchange rate fluctuations, changing market conditions, product competition, the nature of product development, impact of acquisitions and divestitures, restructurings, products withdrawals, regulatory approval processes, all-in scenario of R&D projects and other unusual items. Consequently, actual results or future events may differ materially from those expressed or implied by such forward-looking statements. Should known or unknown risks or uncertainties materialize, or should our assumptions prove inaccurate, actual results could vary materially from those anticipated. The Company undertakes no obligation to publicly update or revise any forward-looking statements. This document does not constitute an offer to sell, or the solicitation of an offer to subscribe for or buy, any securities. Forenote 2
Page 3
TABLE OF CONTENTS 01 02 03 04 Introduction Philippe Kehren Financials Alexandre Blum Q&A Philippe Kehren Outlook Philippe Kehren
Page 4
4 01 INTRODUCTION Philippe KEHREN
Page 5
Safety at the heart of our operations 3 0 4 4 0 3 3 1 1 0 3 0.27 0.24 0.30 0.29 0.31 0.33 0.29 0.33 0.30 0.26 0.29 -1 1 3 5 7 9 11 13 15 0 0.05 0.1 0.15 0.2 0.25 0.3 0.35 0.4 0.45 0.5 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 High severity reportable injuries Reportable Injury Rate
Page 6
6 Key messages Q3 For InformationFor Information Saudi Arabia HPPO plant Energy and logistics costs 6 Feedstock secured with Viridis Ongoing JV discussion with OneIM Continued Headwinds from Middle East conflict Mixed business performance Seaborne soda ash pricing Continued disciplined investments in growth areas Rare Earths strategic developments
Page 7
02 FINANCIALS Alexandre BLUM
Page 8
Q3/9M 2026 results Impacted by Middle East conflict and continued soda ash weakness -3.3% (organic basis) -26.6% (organic basis) 16.8% margin €25m in Q3 €54m in Q3 2.4x leverage 1. To Solvay shareholders from continuing operations Underlying NET SALES Q3 2026 Underlying EBITDA Q3 2026 COST SAVINGS YTD Underlying NET DEBT Sept 2026 FREE CASH FLOW1 YTD €1.03bn €173m €72m €1.8bn€70m 8
Page 9
Q3 2025 Scope Forex conversion Volume & mix Price Q3 2026 1,044 - +22 -54 +19 1,031 -3.3% -1.3% Q3 underlying Net Sales bridge Stable sales with pricing and FX offsetting lower volume Volumes down yoy (-5.2%) Peroxides plant temporary shutdown in Jubail Lower soda ash volumes Positive pricing (+1.8%) Pricing pressure in sodaash seaborne remains Improved pricing in Coatis, and in Silica and Special Chem from formula indexations Forex tailwind Mainly from BRL 9
Page 10
Q3 2025 Scope Forex conversion Volume & mix Net pricing Fixed costs Other Q3 2026 232 - +4 -65 -29 +11 +20 173 -26.6% -25.3% Q3 underlying EBITDA bridge Middle East conflict negatively impacting volume and net pricing MARGIN 22.2% MARGIN 16.8%-5.4pp Volume & mix c. €-40m 2025 CO2 emissions rights sales Lower Peroxides volumes Net pricing Down mostly from soda ash Improved in Coatis, resilient in other GBUs Fixed costs and Other Operational savings more than offsetting inflation 10
Page 11
Basic Chemicals results Negative impact from the Middle East conflict Q3 2026 (€m) % YoY % YoY organic Soda Ash & Derivatives 398 -7% -8% Peroxides 211 -8% -10% uNet Sales 609 -7% -8% uEBITDA 123 -19% -20% uEBITDA Margin 20.2% Soda ash volumes slightly down in domestic markets, flat in seaborne markets but with lower pricing Bicarbonate business remains very steady Operations at HPPO site in Saudi Arabia still halted Strong growth in electronic grades continues Soda Ash & Derivatives Peroxides Q3 Highlights 11
Page 12
Performance Chemicals results Sales and EBITDA up from improved performance Coatis,strong resilience in Silica and Spec Chem Q3 2026 (€m) % YoY % YoY organic Silica 133 +9% +7% Coatis 138 +19% +11% Special Chem 152 +0% -1% Net Sales 422 +9% +5% uEBITDA 72 +22% +17% uEBITDA Margin 17.1% Q3 Highlights 12 Stable volumes. Price increases from formula pass -through clauses Improved pricing in both phenol and solvents product lines. Lower volumes in autocatalysis offset by higher demand in rare earths electronics applications and from fluorine in North America. Silica Coatis Special Chem
Page 13
Underlying EBITDA Capex Working capital Provisions Taxes & Others Financing FCF to Solvay Shareholders 579 -203 -105 -152 -7 -43 70 Strict Capex discipline while provisions remain elevated FCF generation of €70m YTD Capex €-203m, strict discipline in Capex spending Working Capital €-105m at Q3 Expected decrease by year-end Provisions €-152m still above normalized level from restructuring projects Taxes and others Incl. €28m one-off insurance gain 13
Page 14
December 31, 2025 FCF to Solvay share- holders Dividends to Solvay share- holders In/outflow from M&A Other September 30, 2026 -1,597 70 -254 -11 1 -1,792 S&P RATING: BBB- Stable outlook Underlying net debt: €1.8 Bn Employee benefits liabilities: €0.6 Bn Environmental liabilities: €0.5 Bn Leverage ratio: 2.4x Capital structure Net debt temporarily increased, sequentially slightly down 14
Page 15
03 Philippe KEHREN OUTLOOK
Page 16
1 Assumin g a 1.20 EUR/USD exchange rate 2 Free Cash Flow to Solvay shareholders from continuin g operations 2026 REVISED OUTLOOK Excluding potential revenue or recovery measures from Sadara Free Cash Flow 2 Between €120 & €150 million (net of €90 million of transformation expenses) Capex Below €300 million Underlying EBITDA Between €720 & €740 million1 (net of €40 million of transformation expenses) 16
Page 17
04 Q&A
Page 18
18 THANK YOU Contact media relations Contact investor relations Visit solvay.com Visit solvay.com